NYSEARCA:MLPZ UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B (MLPZ) Price, Holdings, & News $3.95 0.00 (0.00%) As of 03/23/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B (NYSEARCA:MLPZ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MLPZ alerts:Sign Up Key Stats Today's Range$3.60▼$4.0750-Day Range$3.95▼$3.9552-Week Range$1.91▼$35.87Volume23,100 shsAverage Volume7,284 shsMarket Capitalization$2.96 millionAssets Under Management$2.99 millionDividend Yield114.94%Net Expense Ratio0.95%Aggregate RatingN/A ETF Overview Read More UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B ExpensesTypeMLPZNYSEARCA ETFsAll ETFsManagement Fee0.00%0.51%0.53%Other Expenses0.00%0.59%0.56%Total Expense0.00%0.74%0.73%Fee Waiver0.00%-0.71%-0.63%Net Expense0.95%0.58%0.60% Receive MLPZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B and its competitors with MarketBeat's FREE daily newsletter. Email Address MLPZ ETF News HeadlinesFNGO MicroSectors™ FANG+™ Index 2X Leveraged ETNAugust 31, 2024 | seekingalpha.comJackson Hole Could Spark a Dollar Comeback, UBS SaysAugust 27, 2024 | barrons.comOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas. | InvestorPlace (Ad)UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerBApril 5, 2024 | money.usnews.comQ4 2023 Midstream/MLP Dividend Recap: The Growth ContinuesFebruary 28, 2024 | seekingalpha.comSee More Headlines MLPZ ETF - Frequently Asked Questions How have MLPZ shares performed this year? UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B's stock was trading at $3.95 at the beginning of the year. Since then, MLPZ stock has increased by 0.0% and is now trading at $3.95. How do I buy shares of UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B? Shares of MLPZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B own? Based on aggregate information from My MarketBeat watchlists, some other companies that UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B investors own include Cheniere Energy (LNG), Höegh LNG Partners (HMLP), American Midstream Partners (AMID), 10969 (AMI.L) (AMI), Applied Materials (AMAT), Alexander & Baldwin (ALEX) and Apollo Investment (AINV). Fund Details Issuer Fund NameETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MLPZ Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$2.99 million Average Daily Volume$3.85 thousand Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares750,000BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NYSEARCA:MLPZ) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B Please log in to your account or sign up in order to add this asset to your watchlist. Share UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
